Blood monocyte subsets and selected cardiovascular risk markers in rheumatoid arthritis of short duration in relation to disease activity

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Klimek, Ewa ^a   Mikołajczyk, Tomasz ^a   Sulicka, Joanna ^a   Kwas̈ny Krochin, Beata ^a   Korkosz, Mariusz ^a   Osmenda, Grzegorz ^a   Wizner, Barbara ^a   Surdacki, Andrzej ^a   Guzik, Tomasz ^a   Grodzicki, Tomasz K ^a   Skalska, Anna ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD14 ANTIGEN; CD16 ANTIGEN; CD18 ANTIGEN; CD45RA ANTIGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HLA DR ANTIGEN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; FC RECEPTOR; FCGR3B PROTEIN, HUMAN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN;

ADULT; ANTIGEN EXPRESSION; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR RISK; CELL SUBPOPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DAS28; DIASTOLIC BLOOD PRESSURE; DISEASE ACTIVITY; DISEASE DURATION; FEMALE; HUMAN; HUMAN CELL; MALE; MEAN ARTERIAL PRESSURE; MONOCYTE; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; BLOOD; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; CELL LINEAGE; COMPLICATION; IMMUNOLOGY; LEUKOCYTE COUNT; MIDDLE AGED; PATHOLOGY; RISK FACTOR;

ADULT; ANTIGENS, CD14; ARTHRITIS, RHEUMATOID; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; CAROTID INTIMA-MEDIA THICKNESS; CELL LINEAGE; FEMALE; GPI-LINKED PROTEINS; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MONOCYTES; RECEPTORS, IGG; RISK FACTORS;

EID: 84928561800     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/736853     Document Type: Article

References (41)

1. R. W. Kinne, R. Brauer, B. Stuhlmuller, E. Palombo-Kinne, and G. Burmester, "Macrophages in rheumatoid arthritis, " Arthritis Research, vol. 2, no. 3, pp. 189-202, 2000.
2. M. A. Gonzalez-Gay, C. Gonzalez-Juanatey, and J. Martin, "Rheumatoid arthritis: a disease associated with accelerated atherogenesis, " Seminars in Arthritis and Rheumatism, vol. 35, no. 1, pp. 8-17, 2005.
3. Z. Szekanecz, G. Kerekes, H. Der et al. , "Accelerated atherosclerosis in rheumatoid arthritis, " Annals of the New York Academy of Sciences, vol. 1108, pp. 349-589, 2007.
4. R. D. Abeles, M. J. McPhail, D. Sowter et al. , "CD14, CD16 and HLA-DR reliably identifies human monocytes and their subsets in the context of pathologically reducedHLA-DR expression by CD14hi/CD16neg monocytes: expansion of CD14hi/CD16pos and contraction of CD14lo/CD16pos monocytes in acute liver failure, " Cytometry A, vol. 81, no. 10, pp. 823-834, 2012.
5. G. Rothe, H. Gabriel, E. Kovacs et al. , "Peripheral blood mononuclear phagocyte subpopulations as cellular markers in hypercholesterolemia, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 16, no. 12, pp. 1437-1447, 1996.
6. F. Liote, B. Boval-Boizard, D. Weill, D. Kuntz, and J.-L. Wautier, "Blood monocyte activation in rheumatoid arthritis: increased monocyte adhesiveness, integrin expression, and cytokine release, " Clinical and Experimental Immunology, vol. 106, no. 1, pp. 13-19, 1996.
7. N. Sattar, D. W. McCarey, H. Capell, and I. B. McInnes, "Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis, " Circulation, vol. 108, no. 24, pp. 2957-2963, 2003.
8. B. Osterud and E. Bjorklid, "Role of monocytes in atherogenesis, " Physiological Reviews, vol. 83, no. 4, pp. 1069-112, 2003.
9. J. Meerschaert and M. B. Furie, "The adhesion molecules used by monocytes for migration across endothelium include CD11a/CD18, CD11b/CD18, and VLA-4 on monocytes and ICAM-1, VCAM-1, and other ligands on endothelium, " Journal of Immunology, vol. 154, no. 8, pp. 4099-4112, 1995.
10. M. L. Bots, A. Hofman, P. T. De Jong, and D. E. Grobbee, "Common carotid intima-media thickness as an indicator of atherosclerosis at other sites of the carotid artery: the Rotterdam Study, " Annals of Epidemiology, vol. 6, no. 2, pp. 147-153, 1996.
11. P. Pignoli, E. Tremoli, A. Poli, P. Oreste, and R. Paoletti, "Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging, " Circulation, vol. 74, no. 6, pp. 1399-1406, 1986.
12. N. S. Sahari, S. S. Shaharir, M. R. Ismail, S. Rajalingham, and M. S. M. Said, "Subclinical atherosclerosis among rheumatoid arthritis patients without overt cardiovascular risk factors, " Modern Rheumatology, 2014.
13. S. Hannawi, B. Haluska, T. H. Marwick, and R. Thomas, "Atherosclerotic disease is increased in recent-onset rheumatoid arthritis: a critical role for inflammation, " Arthritis Research and Therapy, vol. 9, no. 6, article R116, 2007.
14. G. J. De Backer, H. Gohlke, I. Graham et al. , "European Association for Cardiovascular Prevention & Rehabilitation (EACPR); ESC Committee for Practice Guidelines (CPG), " European Heart Journal, vol. 33, no. 13, pp. 1635-1701, 2012.
15. L. Ziegler-Heitbrock, P. Ancuta, S. Crowe et al. , "Nomenclature of monocytes and dendritic cells in blood, " Blood, vol. 116, no. 16, pp. e74-e80, 2010.
16. G. K. Hansson, "Mechanisms of disease: inflammation, atherosclerosis, and coronary artery disease, " The New England Journal of Medicine, vol. 352, no. 16, pp. 1626-1695, 2005.
17. G. H. Heine, C. Ulrich, E. Seibert et al. , "CD14++CD16+ monocytes but not total monocyte numbers predict cardiovascular events in dialysis patients, " Kidney International, vol. 73, no. 5, pp. 622-629, 2008.
18. N. Kawanaka, M. Yamamura, T. Aita et al. , "CD14+, CD16+ blood monocytes and joint inflammation in rheumatoid arthritis, " Arthritis and Rheumatism, vol. 46, no. 10, pp. 2578-2586, 2002.
19. M. Rossol, S. Kraus, M. Pierer, C. Baerwald, and U. Wagner, "The CD14brightCD16+ monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population, " Arthritis & Rheumatism, vol. 64, no. 3, pp. 671-677, 2012.
20. D. L. Cooper, S. G. Martin, J. I. Robinsonet al. , "FcRIIIa expression on monocytes in rheumatoid arthritis: Role in immunecomplex stimulated TNF production and non-response to methotrexate therapy, " PLoSONE, vol. 7, no. 1, Article IDe28918, 2012.
21. E. Klimek, A. Skalska, B. Kwasny-Krochin et al. , "Differential associations of inflammatory and endothelial biomarkers with disease activity in rheumatoid arthritis of short duration, " Mediators of Inflammation, vol. 2014, Article ID681635, 11pages, 2014.
22. F. C. Arnett, S. M. Edworthy, D. A. Bloch et al. , "The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis, " Arthritis & Rheumatism, vol. 31, no. 3, pp. 315-324, 1988.
23. M. L. Prevoo, M. A. van T Hof, H. H. Kuper, M. A. van Leeuwen, L. B. van de Putte, and P. L. van Riel, "Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis, " Arthritis and Rheumatism, vol. 38, no. 1, pp. 44-48, 1995.
24. J. Sulicka, A. Surdacki, T. Mikoajczyk et al. , "Elevated markers of inflammation and endothelial activation and increased counts of intermediate monocytes in adult survivors of childhood acute lymphoblastic leukemia, " Immunobiology, vol. 218, no. 5, pp. 810-816, 2013.
25. I. Heimbeck, T. P. J. Hofer, C. Eder et al. , "Standardized singleplatform assay for human monocyte subpopulations: lower CD14+CD16++ monocytes in females, " Cytometry A, vol. 77, no. 9, pp. 823-830, 2010.
26. M. Siedlar, M. Strach, K. Bukowska-Strakova et al. , "Preparations of intravenous immunoglobulins diminish the number and proinflammatory response of CD14+CD16++ monocytes in common variable immunodeficiency (CVID) patients, " Clinical Immunology, vol. 139, no. 2, pp. 122-132, 2011.
27. A. Zanchetti, M. G. Bond, M. Hennig et al. , "Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis, " Journal of Hypertension, vol. 16, no. 7, pp. 949-961, 1998.
28. A. M. van Sijl, M. J. Peters, D. K. Knol et al. , "Carotid intima media thickness in rheumatoid arthritis as compared to control subjects: a meta-analysis, " Seminars in Arthritis and Rheumatism, vol. 40, no. 5, pp. 389-397, 2011.
29. I. D. del Rincon, K. Williams, M. P. Stern, G. L. Freeman, and A. Escalante, "High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors, " Arthritis & Rheumatology, vol. 44, pp. 2737-2745, 2001.
30. A. Gonzalez, H. Maradit Kremers, C. S. Crowson et al. , "Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients" Annals of the Rheumatic Diseases, vol. 67, no. 1, pp. 64-69, 2008.
31. P. Libby, P. M. Ridker, and G. K. Hansson, "Progress and challenges in translating the biology of atherosclerosis, " Nature, vol. 473, no. 7347, pp. 317-325, 2011.
32. S. Hannawi, T. H. Marwick, and R. Thomas, "Inflammation predicts accelerated brachial arterial wall changes in patients with recent-onset rheumatoid arthritis, " Arthritis Research and Therapy, vol. 11, no. 2, article R51, 2009.
33. A. A. Neto, A. de Padua Mansur, S. D. Avakian, E. P. Gomes, and J. A. Ramires, "Monocytosis is an independent risk marker for coronary artery disease, " Arquivos Brasileiros de Cardiologia, vol. 86, no. 3, pp. 240-244, 2006.
34. K. E. Berg, I. Ljungcrantz, L. Andersson et al. , "Elevated CD14++CD16-monocytes predict cardiovascular events, " Circulation: Cardiovascular Genetics, vol. 5, no. 1, pp. 122-131, 2012.
35. D. Brohee and N. Higuet, "In vitro stimulation of peripheral blood mononuclear cells by phytohaemagglutinin A induces CD45RA expression on monocytes, " Cytobios, vol. 71, no. 285, pp. 105-111, 1992.
36. H. Gabriel, A. Urhausen, L. Brechtel, H. J. Muller, and W. Kindermann, "Alterations of regular and mature monocytes are distinct, and dependent of intensity and duration of exercise, " European Journal of Applied Physiology and Occupational Physiology, vol. 69, no. 2, pp. 179-181, 1994.
37. P. Ancuta, R. Rao, A. Moses et al. , "Fractalkine preferentially mediates arrest and migration of CD16+monocytes, " Journal of Experimental Medicine, vol. 197, no. 12, pp. 1701-1707, 2003.
38. P. Ancuta, A. Moses, and D. Gabuzda, "Transendothelial migration of CD16+ monocytes in response to fractalkine under constitutive and inflammatory conditions, " Immunobiology, vol. 209, no. 1-2, pp. 11-20, 2004.
39. O. Krystufkova, H. Mann, H. Hulejova, L. Senolt, and J. Vencovsky, "A1. 48 Enhanced expression of CD11c on non-classical CD16+ peripheral blood monocytes in early rheumatoid arthritis, " Annals of the Rheumatic Diseases, vol. 73, supplement 1, pp. A20-A21, 2014.
40. C. Sadhu, H. J. Ting, B. Lipsky et al. , "CD11c/CD18: novel ligands and a role in delayed-type hypersensitivity, " Journal of Leukocyte Biology, vol. 81, no. 6, pp. 1395-1403, 2007.
41. C. Sunderkotter, T. Nikolic, M. J. Dillon et al. , "Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response, " Journal of Immunology, vol. 172, no. 7, pp. 4410-4417, 2004.